IOP-lowering effect and tolerability of prostaglandin analogues in primary open-angle glaucoma and ocular hypertension as risk factors for glaucoma progression
A.V. Belogurova<sup>1</sup>, E.N. Eskina<sup>1</sup>, J.G. Oganezova<sup>2</sup><br> <sup>1</sup>LLC “Сlinic “Sphere”, Moscow, Russian Federation<br> <sup>2</sup>Pirogov Russian National Research Medical University, Moscow, Ru...
Saved in:
Main Authors: | A.V. Belogurova, E.N. Eskina, Zh.G. Oganezova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Prime-Media
2019-04-01
|
Series: | РМЖ "Клиническая офтальмология" |
Online Access: | http://clinopht.com/upload/iblock/9bc/9bcd3d19d576a59fd8f3542333f7dcc1.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IOP-lowering therapy and ocular surface in glaucoma. Part 1. The effects of drug substances of glaucoma medications on the ocular surface
by: A.V. Antonova, et al.
Published: (2020-06-01) -
Characteristics of glaucoma therapy with prostaglandin analogues nowadays
by: I.B. Alekseev, et al.
Published: (2022-09-01) -
IOP-lowering therapy and ocular surface in glaucoma. Part 2. The effect of preservatives on ocular surface
by: A.V. Antonova, et al.
Published: (2020-08-01) -
Modalities for the treatment of primary open-angle glaucoma
by: Zh.G. Oganezova, et al.
Published: (2019-09-01) -
Prolonging IOP-lowering effect of glaucoma surgery
by: I.B. Alekseev, et al.
Published: (2019-07-01)